Importance of Accurate Identification and Antifungal Susceptibility Testing of Aspergillus Species in Clinical Settings
Medical Mycology Journal · 2023
DOI: 10.3314/mmj.23-004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Mycology Journal, 2023. Verfasst von Keita Takeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Fungal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital.
- Division of Clinical Research, Medical Mycology Research Center, Chiba University.
Zitieren
APA
Takeda, K., Suzuki, J., Sasaki, Y., Watanabe, A., & Kamei, K. (2023). Importance of Accurate Identification and Antifungal Susceptibility Testing of Aspergillus Species in Clinical Settings. Medical Mycology Journal. https://doi.org/10.3314/mmj.23-004
Vancouver
Takeda K, Suzuki J, Sasaki Y, Watanabe A, Kamei K. Importance of Accurate Identification and Antifungal Susceptibility Testing of Aspergillus Species in Clinical Settings. Medical Mycology Journal. 2023. doi:10.3314/mmj.23-004
BibTeX
@article{Takeda2023,
author = {Takeda, Keita and Suzuki, Junko and Sasaki, Yuka and Watanabe, Akira and Kamei, Katsuhiko},
title = {Importance of Accurate Identification and Antifungal Susceptibility Testing of Aspergillus Species in Clinical Settings},
journal = {Medical Mycology Journal},
year = {2023},
doi = {10.3314/mmj.23-004}
}
EUVIMED